A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp

Clinical trial NCT05231044 · COMPLETED

Trial details

NCT number: NCT05231044
Sponsor: PharmaEssentia
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2021-12-21
Primary completion: 2023-11-20
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.